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Mammalian SIRT1 Represses
Forkhead Transcription Factors
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1993; Kimura et al., 1997). DAF-2 is coupled to a series
of kinases, including AKT kinase, which phosphorylate
the forkhead family transcription factor DAF-16 causingSummary
its retention in the cytoplasm (Ogg et al., 1997; Lin et
al., 1997). Thus, mutations in daf-2 lead to the transloca-The NAD-dependent deacetylase SIR2 and the fork-
tion of DAF-16 to the nucleus, where it is active (Hender-head transcription factor DAF-16 regulate lifespan in
son and Johnson, 2001; Lin et al., 2001; Lee et al., 2001).model organisms, such as yeast and C. elegans. Here
DAF-16 activity is required in daf-2 mutants for the entrywe show that the mammalian SIR2 ortholog SIRT1
into dauer in larvae and for the extended lifespan indeacetylates and represses the activity of the forkhead
adults (Kenyon et al., 1993; Kimura et al., 1997).transcription factor Foxo3a and other mammalian
Genetic data in C. elegans suggest that the long life-forkhead factors. This regulation appears to be in the
span conferred by extra copies of sir-2.1 will extend theopposite direction from the genetic interaction of SIR2
lifespan in wild-type but not in daf-16 mutants, indicatingwith forkhead in C. elegans. By restraining mammalian
that in worms, SIR-2 requires DAF-16 for longevity (Tis-
forkhead proteins, SIRT1 also reduces forkhead-
senbaum and Guarente, 2001). However, the mecha-
dependent apoptosis. The inhibition of forkhead activ- nism by which SIR-2.1 may regulate insulin signaling to
ity by SIRT1 parallels the effect of this deacetylase on activate DAF-16 is not known.
the tumor suppressor p53. We speculate how down- In mammals, both SIR2 and forkhead genes are con-
regulating these two classes of damage-responsive served and play important roles in cellular and organis-
mammalian factors may favor long lifespan under cer- mal biology. SIR2 is represented by seven homologs,
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striction. dependent deacetylase (Imai et al., 2000) that deacet-
ylates and downregulates the p53 tumor suppressor
Introduction (Luo et al., 2001; Vaziri et al., 2001). Accordingly, in-
creased SIRT1 activity in cultured cells reduces p53-
Over the past several years, numerous genes have been mediated apoptosis in response to radiation or oxidative
identified that alter the lifespan of model organisms. stress. SIRT1 has also been shown to repress the termi-
One of these is SIR2, which encodes an NAD-dependent nal differentiation in dividing myocytes by binding to the
protein deacetylase (Imai et al., 2000; Landry et al., 2000; myoD cofactor, pCAF (Fulco et al., 2003). In these cases,
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Burney et al., 2003; Cheng et al., 2003). In outcrossed In addition, we carried out coimmunoprecipitation of
transfected SIRT1 (tagged with Myc) and p300 (taggedbackgrounds, rare homozygous knockout mice survive
to adulthood and are invariably smaller than wild-type with HA) (Figure 1B). The dominant-negative mutant of
SIRT1 (dn) changing an active site His to Ala (Imai etand sterile. Consistent with the possibility that SIRT1
regulates p53 in vivo, these knockout adults display al., 2000; Luo et al., 2001) was also used in this assay.
Transfection with SIRT1 (lanes 1 and 4) or the SIRT1dnhyperacetylated p53 and show increased apoptosis, at
least in thymocytes (Cheng et al., 2003) and spermato- (lanes 2 and 5) gave rise to elevated levels of SIRT1,
visualized by blotting with an anti-Myc antibody (bottomgonia (McBurney et al., 2003).
The forkhead (or winged helix) proteins are structurally panel). Extracts were immunoprecipitated with anti-HA
and blotted with anti-Myc antibody. Transfection ofrelated transcriptional activators of which the mamma-
lian Foxo members Foxo1, Foxo3a, and Foxo4 represent SIRT1 (lane 1, top), SIRT1dn (lane 2, top), or HA-p300
in the absence of SIRT1 (lane 3, top) did not result in aa subfamily that are regulated by growth factors through
the activation of the PtdIns-3-kinase pathway (Tran et signal of SIRT1 in the precipitate. In contrast, cotrans-
fection of HA-p300 and SIRT1 (lane 4, top) or SIRT1dnal., 2003). Growth factor-induced activation of PtdIns-
3-kinase leads to an increase in the activity of the ser/ (lane 5, top) gave rise to a strong SIRT1 signal in the
precipitate. In a reciprocal experiment, cells were trans-threonine kinase AKT/PKB (Anderson et al., 1998; Ste-
phens et al., 1998), which in turn leads to phosphoryla- fected with HA-p300 (lane 6) or HA-p300 and myc-
SIRT1dn (lane 7). Immunoprecipitation with anti-myc fol-tion and inactivation of Foxo proteins by retention in the
cytoplasm (Rena et al., 2001; Cahill et al., 2001; Brunet lowed by blotting with anti-HA showed that p300 was
pulled down only when cotransfected with SIRT1. Theseet al., 2002; Tzivion et al., 2001).
Under conditions that activate Foxo proteins, such as experiments indicate that p300 can interact with SIRT1
or the dn mutant.serum withdrawal, Foxo proteins move from the cyto-
plasm to the nucleus, where they activate or repress
suites of genes (Ramaswamy et al., 2002; Murphy et al., SIRT1 Represses the Ability of Foxo3a
2003). Depending on the activation signal, Foxo can to Activate Transcription
regulate apoptosis (Brunet et al., 1999; Nakamura et al., In a first attempt to determine whether SIRT1 could alter
2000; Tang et al., 2002), cell cycle arrest (Dijkers et al., the activity of Foxo3a, HeLa cells were transfected with
2000; Kops et al., 2002b; Medema et al., 2000), differenti- a luciferase construct driven by the promoter of the
ation (Hribal et al., 2003; Bois and Grosveld, 2003; Nakae forkhead target gene, bim, a proapoptotic factor (Dijkers
et al., 2003), or the activation of genes involved in DNA et al., 2000). Expression vectors for Foxo3a, or Foxo3a
repair (Tran et al., 2002; Furukawa-Hibi et al., 2002) and plus SIRT1 or SIRT1dn, were also transfected, as indi-
oxidative stress resistance (Murphy et al., 2003; Kops cated (Figure 2A). The Foxo3a expression vector used
et al., 2002a; Nemoto and Finkel, 2002). in this experiment actually expresses a mutant Foxo3a,
Other genes activated by Foxo in mammals, such as Foxo3aA3, in which the three phosphorylation sites for
PEPCK, control the gluconeogenic pathway that drives AKT/PKB are mutated to alanine, thereby rendering nu-
the production of glucose in the liver upon starvation clear localization as constitutive.
(Daitoku et al., 2003; Barthel et al., 2001; Nakae et al., Transfection with the Foxo3a expression vector (lane
2001). Indeed, the reduced level of Foxo1 in heterozy- 2) gave rise to transactivation of the luciferase construct
gous mice suppresses a diabetic phenotype induced in compared to transfection with a vector control (lane
mice heterozygous for the insulin receptor gene (Nakae 1). Activation by Foxo3aA3 was largely repressed by
et al., 2002). cotransfection of a SIRT1 expression vector (lane 5) but
In this study, we examine a possible connection be- only partially repressed by the SIRT1dn (lane 6). The
tween SIRT1 and Foxo3a in mammalian cells. Our find- SIRT1 or SIRT1dn constructs did not affect the activity
ings indicate that SIRT1 deacetylates and downregu- of luciferase in cells that were not transfected with Fox-
lates forkhead proteins. The implications of these o3aA3 (lanes 3 and 4). These findings suggest that SIRT1
findings for the biology of aging in mammals will be dis- can repress Foxo3a and that the deacetylase activity
cussed. contributes to repression. To further test whether the
deacetylase activity plays a role in repression, we added
10 mM nicotinamide, known to block the enzymatic ac-Results
tivity of SIRT1. Nicotinamide prevented repression by
SIRT1 (lane 5) but did not affect the mild repression byBinding of SIRT1 to Foxo3a and to p300
Human embryonic kidney cells (HEK293T) were trans- SIRT1dn (lane 6).
In a second experiment, HeLa cells were transfectedfected with Ha-tagged Foxo3a, Flag-tagged SIRT1, or
both. Immunoprecipitation with anti-Flag and blotting with a luciferase reporter construct driven by synthetic
Foxo binding sites (DBE) plus expression vectors forwith anti-Flag (Figure 1A) showed SIRT1 in lanes 2 and
3, as expected. Likewise, immunoprecipitation with anti- Foxo3a (all lanes), as well as SIRT1 or PTEN, a 3-phos-
phoinositide phosphatase (Figure 2B). PTEN expressionHA and blotting with anti-HA revealed Foxo3a in lanes
1 and 3, as expected. In the experimental case of immu- is expected to downregulate insulin signaling through
the PtdIns-3-kinase pathway and enhance the activitynoprecipitation with anti-Flag and blotting with anti-HA,
Foxo3a was evident when SIRT1 was cotransfected of Foxo3a. Transfection of the SIRT1 vector repressed
luciferase activity (lane 2) compared to a vector control(lane 3), but not when Foxo3a was transfected alone
(lane 1). This experiment shows that SIRT1 can interact (lane 1). This repression was more manifest in cells
treated with wortmannin (lanes 4 and 5), an inhibitorwith Foxo3a.
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Figure 1. SIRT1 Interacts with Foxo3a and p300
(A) SIRT1 interacts with Foxo3a. HEK293T cells were transfected with HA-Foxo3a (lane 1), Flag-SIRT1 (lane 2), or HA-Foxo3a together with
Flag-SIRT1 (lane 3). Lysates were immunoprecipitated as indicated (left) and Western blotted with the indicated antibodies (right). HA-Foxo3a
is only immunoprecipitated by the Flag antibody when Flag-SIRT1 is present.
(B) SIRT1 interacts with p300. HEK293T cells were transfected with the indicated plasmids lysed and immunoprecipitated with either an anti-
HA antibody (lane 1–5) or an anti-Myc antibody (lanes 6 and 7). Immunoprecipitates were Western blotted and probed with anti-Myc antibody
(lanes 1–5) or with an anti-HA antibody (lanes 6 and 7). The top panel of lanes 1–5 demonstrate that SIRT1 (both wt or the dominant-negative
version dn) is only immunoprecipitated by the HA antibody when HA-p300 is expressed. The lower panel (lanes 1–5) demonstrates that equal
amounts of SIRT1 were expressed in the total cell lysates. Lanes 6 and 7 demonstrate that HA-p300 was only immunoprecipitated by the
Myc antibody when both Ha p300 and SIRT1dn were expressed. Lanes 6 and 7 (bottom panel) demonstrate that the levels of p300 in the
total lysates were comparable.
of the PI3 kinase, which, like PTEN, will downregulate parable levels of the protein in each case (Figure 2D).
The above experiments show that SIRT1 can repressPtdIns-3-kinase signaling and activate Foxo3a. In both
control (lane 3) and wortmannin-treated cells (lane 6), Foxo3a activity, and the catalytically inactive SIRT1 is
less effective.PTEN expression hyperactivated Foxo3a, demonstra-
ting the effectiveness of this reporter assay in reflecting In an analogous study, the activity of Foxo1 (Foxo1A3,
mutated in the three PKB phosphorylation sites) waslevels of signaling in the insulin pathway.
In a third experiment, we analyzed the ability of SIRT1 also repressed by SIRT1 (Figure 3A). In this case, we
examined expression of a luciferase reporter driven byto repress Foxo3a or Foxo3aA3 on promoters of known
target genes, bim and the cell cycle regulator, p27 (Fig- the bim promoter. This reporter was activated by co-
transfection of the Foxo1A3 expression construct (laneure 2C). HeLa cells were transfected with the DBE con-
struct (DBE, lanes 1–5), the p27 promoter (p27, lanes 2) versus a vector control (lane 1). SIRT1 repressed this
activation (lane 3), and the repression was largely abol-6–10), or the BIM promoter (Bim, lanes 11–15). The level
of transcription that was driven by transfection of the ished by nicotinamide (lane 6). Nicotinamide did not
affect the basal activity of the reporter (lane 4) or activa-Foxo3a expression construct alone was arbitrarily set to
100. Repression of Foxo3a (lanes 2 and 3) or Foxo3aA3 tion by Foxo1A3 in the absence of SIRT1 (lane 5).
Finally, luciferase assays were carried out using an(lanes 4 and 5) by SIRT1 was observed on the DBE
construct. Importantly, much stronger repression was expression vector for a third forkhead factor, Foxo4
(Foxo4A3, mutated in the three PKB phosphorylationobserved on the p27 or BIM promoters in similar experi-
ments (lanes 7–10 and 12–15). In order to be certain sites), in U2OS cells. In this case, marked activation of
the reporter by forkhead was observed; this activationthat the repression by SIRT1 or differences between
promoters were not due to differences in Foxo3a expres- was greatly repressed by cotransfection with the SIRT1
expression vector (Figure 3B). In addition, Foxo4A3 alsosion, Western blots were performed and showed com-
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Figure 2. SIRT1 Represses Foxo3a Transcriptional Activity
(A) HeLa cells were transfected as indicated together with the bim-luciferase and -galactosidase reporter construct. Sixteen hours after
transfection, the cells were either maintained as controls (control) or were treated with nicotinamide (10 mM) for a further 16 hr. The data are
normalized with respect to -galactosidase activity and are expressed as a percent of the activity of Foxo3aA3 alone. The data are shown
as the average  the standard deviation of triplicate samples. The data demonstrate that SIRT1 represses the transcriptional activity of
Foxo3aA3 (compare lane 2 and lanes 5 and 6, control. *denotes a p value  0.02). Repression by SIRT1 is significantly reversed by incubation
with nicotinamide (compare lanes 5  nicotinamide. **denotes a p value  0.01).
(B) HeLa cells were transfected with indicated constructs together with the DBE-luciferase and -galactosidase reporter constructs. The data
are normalized with respect to the -galactosidase and are expressed as a % of the activity of Foxo3a alone (control). Transfected cells were
either maintained as controls or were treated with wortmannin and LY294002 as indicated. PTEN is a 3-phosphoinositide phosphatase,
expected to act as a positive regulator of Foxo3a, and demonstrates that the assay procedure is able to discriminate between potential
activators (PTEN) or inhibitors (SIRT1) of Foxo3a activity.
(C) SIRT1 represses Foxo3a-mediated transcription from various promoters. HeLa cells were transfected with the indicated plasmids and
reporter constructs and the -galactosidase reporter. In the cases where the transcriptional activity of Foxo3a was assessed, wortmannin
and LY294002 were added for the final 6 hr. The data are shown as the % of the activity obtained in the Foxo3a sample and are single points
representative of three experiments. The data demonstrate that SIRT1 is more efficient at repressing Foxo3a activity at natural promoters
(p27 and bim).
(D) Repression by SIRT1 cannot be accounted for by changes in the total levels of Foxo3a. Proteins from the samples used for the luciferase
activity (Figure 2C) were separated by SDS-PAGE and probed for HA to detect Foxo3a and Foxo3aA3.
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Figure 3. SIRT1 Represses Foxo1 and Foxo4
(A) SIRT1 represses Foxo1 activity in a nicotinamide-dependent manner. HeLa cells were transfected with the indicated constructs together
with the bim-luciferase and -galactosidase reporter constructs. Sixteen hours after transfection, the cells were either maintained as controls
or were treated with 10 mM nicotinamide (as indicated) for a further 16 hr. The Foxo1 construct is a constitutively active form in which the
PKB phosphorylation sites were mutated (Foxo1A3). The data are normalized to -galactosidase and presented as a percent of the activity
obtained in Foxo1A3 alone. The data are shown as the average  the standard deviation. The data (compare lanes 2 and 3) demonstrate that
SIRT1 represses Foxo1A3 activity (* denotes a p value  0.001) and that this repression is blocked by incubation with 10 mM nicotinamide
(compare lanes 3 and 6. **denotes a p value  0.002).
(B) SIRT1 negatively regulates transcription induced by Foxo4. U2OS cells were transfected as indicated together with the pGL2-3XIRS-luc
and -galacosidase reporter constructs. The Foxo4 construct is the mutant form in which the PKB phosphorylation sites T28, S193, and S258
were converted to alanines (Foxo4A3). The data are normalized for -galacosidase and shown as the average  the standard deviation.
(C) SIRT1 inhibits apoptosis induced by Foxo4. H1299 cells were transfected with Foxo4A3 and/or SIRT1 as indicated together with GFP as
a sorting control. Forty-eight hours after transfection, the cells were fixed, stained with propidium iodide, and analyzed for apoptotic cells
(sub-G1) by flow cytometry. The data are presented as the % of green cells  the standard deviation.
caused efficient apoptosis of H1299 cells (Figure 3C). extracts were equilibrated for roughly comparable levels
of p300 and Foxo3a (lanes 1–5) and the extracts wereThis also was strongly repressed by SIRT1. These find-
ings indicate that the repression of Foxo3a by SIRT1 processed further. Foxo3a (and p300) was immunopre-
cipitated with anti-HA and subsequently analyzed. Simi-applies to other forkhead family members.
lar amounts of total HA-Foxo3a were brought down in
all cases, as determined by blotting the precipitates withSIRT1 Deacetylates Foxo3a and p300
and Represses p300-Mediated anti-HA (lanes 1–5, middle). The precipitates were also
blotted with anti-acetyl-lysine (lanes 1–5, top). Acet-Activation of Foxo3a
The above experiments suggested that SIRT1 represses ylated Foxo3a was observed in cells cotransfected with
Foxo3a and p300 (lane 2, top) but not in cells trans-the activity of forkhead proteins. To test whether SIRT1
deacetylated forkhead, we transfected HEK293T cells fected with Foxo3a alone (lane 1, top). SIRT1 expres-
sion virtually abolished the appearance of acetylatedwith HA-Foxo3a (Figure 4A, all lanes), p300 (lane 2), and,
in some cases, p300 and SIRT1 (lanes 3–5). Total cell Foxo3a (lanes 3–5, top), indicating that Foxo3a can be
Cell
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Figure 4. SIRT1 Deacetylates Foxo3a and p300
(A) HEK293T were transfected with the indicated constructs and lysed 36 hr later. Total cell lysates were Western blotted for the presence
of HA-p300, HA-Foxo3a, and SIRT1 (lanes 1–5). Comparable levels of p300 (lanes 2–5) and Foxo3a (lanes 1–5) were immunoprecipitated using
antibodies either directed against acetylated-lysine (lanes 1–5, bottom panel) or the HA epitope (lanes 1–5, top panels) and Western blotted
for the presence of HA epitope (in the case of immunoprecipitation with anti-acetyl-lysine antibodies, bottom panel) or for acetylated-lysine
residues (in the case of immunoprecipitation with the HA antibody, top panel). The data demonstrate that cotransfection with p300 leads to
Foxo3a acetylation (compare lanes 1 and 2), which is reversed by SIRT1 expression (compare lanes 3–5 with lane 2). The blot of the HA
immunoprecipitate was reprobed using the anti-HA antibody to demonstrate approximately equal presence of HA-Foxo3a (1–5, middle panel).
(B) Endogenous Foxo3a is acetylated in response to UV irradiation and oxidative stress. HeLa cells were maintained either as controls,
irradiated with 200 joules/cm2 UVC (UV), or treated with H202 (500 m). Growth medium was replaced and cells were incubated for 2 hr after
which the indicated deacetlylase inhibitors were added for a further hour. The endogenous Foxo3a was immunoprecipitated and Western
blotted using antibodies directed against acetylated-lysine residues (top panel). The blot was reprobed for the total amount of Foxo3a (bottom
panel). Acetylation was enhanced by nicotinamide (NIC) or TSA.
(C) SIRT1 deacetylates p300. HEK293T cells were transfected as indicated, lysed, immunoprecipitated with an anti-Ha antibody, and Western
blotted using an anti-acetyl-lysine antibody (top panel). The data demonstrate that p300 is acetylated when expressed in HEK293T cells
(compare lanes 1 and 3) and that this acetylation is a target for SIRT1 deacetylase activity (compare lane 3 with lanes 4–6). The HA-IP blot
was reprobed for the HA epitope (middle panel) to demonstrate that approximately equal amounts of p300 were present in the immunoprecipi-
tates. Lysates were immunoblotted to demonstrate equal amounts of SIRT1 or SIRT1dn (bottom panel).
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deacetylated by SIRT1. In a reciprocal experiment, we 4–5) or SIRT1dn (lanes 6–7). In this experiment, we moni-
immunoprecipitated the extracts with anti-acetyl-lysine tored expression of the endogenous p27 gene by a
and blotted with anti-HA (lanes 1–5, bottom). Again, Western blot for p27 protein (results were also confirmed
this experiment showed that Foxo3a was acetylated by by RT-PCR, not shown). The Foxo3a vector activated
p300 and deacetylated by SIRT1. p27 levels (lane 2) compared to a vector control (lane
We next addressed whether endogenous Foxo3a was 1). Cotransfection of p300 further stimulated p27 (lane
acetylated upon UV or oxidative stress conditions, which 3). This activation by Foxo3a and p300 was completely
should activate the protein to turn on target genes for eliminated by cotransfection of SIRT1 (lanes 4 and 5).
stress management. The endogenous Foxo3a was im- In contrast, activation was not prevented by cotransfec-
munoprecipitated from HeLa cells and blotted with the tion of SIRT1dn (lane 6). These findings bolster the claim
anti-acetyl-lysine or anti-Foxo3a antibodies. As shown that p300 activates Foxo3a and SIRT1 prevents this.
in Figure 4B, both UV and H2O2 treatment trigger acety- Note that the ability of p300 and SIRT1 to activate and
lation of Foxo3a. The levels of Foxo3a protein also ap- repress Foxo3a correlates very well with their ability to
pear higher in UV-treated cells (our preliminary results acetylate and deacetylate the protein (Figure 4A). The
indicate that acetylated Foxo3a is more stable than activation of p27 appears partially blunted at the higher
unacetylated Foxo3a [not shown]). As a test of SIRT1 levels of SIRT1dn (lane 7). These findings may be an
involvement in deacetylation of the endogenous Foxo3a, indication of residual deacetylase activity of the SIRTdn
we treated these cells with the SIRT1 inhibitor, nicotin- mutation. Alternatively, they may suggest a deacetyla-
amide (NIC), and found a further enhancement of acety- tion-independent activity of SIRT1.
lation for both stressors. Treatment with the inhibitor
of non-sirtuin histone deacetylases TSA also elicited
greater acetylation of Foxo3a upon UV stress. These Expression of Foxo Target Genes in SIRT1
results parallel findings with stress-activated p53 using Knockout Mice
these inhibitors (Luo et al., 2001; Vaziri et al., 2001). We next examined the effects of the SIRT1 knockout
We also assessed whether SIRT1 would deacetylate mutation on Foxo activity in embryonic stem (ES) cells
p300. HEK293T cells were transfected with Foxo3a (Fig- and KO mice. ES cells were transfected with a luciferase
ure 4C, lanes 2–9), HA-p300 (lanes 3–9), SIRT1 (lanes reporter driven by Foxo DNA binding sites (Figure 7A).
4–6), and SIRT1dn (lanes 7–9). Extracts were immuno- SIRT1/ ES cells supported a higher level of luciferase
precipitated with anti-HA and blotted for HA (middle) activity than wild-type ES cells (lanes 1 and 2). To obtain
or anti-acetylated-lysine (top). Increasing amounts of further evidence that it was Foxo activity that we were
SIRT1 protein (lanes 4–6) or SIRT1dn (lanes 7–9) were measuring in these cells, we transfected them with
present in extracts from SIRT1-transfected cells (bot- Foxo3a and repeated the assays. Foxo3a gave higher
tom). Also, comparable amounts of p300 were precipi- levels of reporter activity in wild-type cells (lane 3), and
tated from transfected cells (middle, lanes 3–9). p300 this activity was again derepressed in SIRT1/ cells
was clearly acetylated in p300 transfected cells (lane 3, (lane 4). Reintroduction of SIRT1 into the SIRT1/ ES
top) and, strikingly, was deacetylated by SIRT1 (lanes cells restored repression of the reporter (not shown).
4–6) but to a much lesser degree by SIRT1dn (lanes Thus, SIRT1 represses Foxo activity in ES cells.
7–9). Thus, p300, like Foxo3a, is deacetylated by SIRT1. In Figure 7B, we show two pairs of littermates of geno-
We next determined whether the p300 acetylase and types SIRT1/ (lanes 1, 1), / (lanes 3, 3), and /
SIRT1 deacetylase influenced the ability of Foxo3a to (lanes 2, 2 and 4, 4). Liver and kidney tissues were
activate transcription. HEK293T cells were transfected harvested, RNA extracted, and probed for the forkhead
with the Foxo3a expression vector (Figure 5A, lanes 2–9) target gene PEPCK by Northern blot. Expression was
or a vector control (lane 1). Increasing amounts of the elevated in the liver (left panel) and kidney (right panel)
p300 expression vector were cotransfected without
of the / mice compared to the wild-type or /
SIRT1 (lanes 2–5) or in addition to the SIRT1 vector
controls. In Figure 7C, a similar analysis was carried out
(lanes 6–9). In extracts, SIRT1 expression was constant
for IGFBP1 mRNA, another known forkhead target, on(lanes 6–9, middle), while slight increases in Foxo3a lev-
livers from two pairs of littermates (AB and CD) with theels were observed with increasing levels of p300 (bottom
indicated genotypes. Again, expression was higher inpanel). Cells used in lanes 1–9 above had also been
the / mice than in the wild-type littermates.cotransfected with a luciferase vector driven by the bim
Finally, to demonstrate that SIRT1 is present at Foxopromoter, along with a -galactosidase vector driven
DNA sites in vivo, livers of / and / mice wereby a constitutively active SV40 promoter. Expression of
harvested and subject to chromatin immunoprecipita-luciferase and -galactosidase were determined in all
tion, using SIRT1 or several control antibodies (Figurecases (Figure 5B). Compared to the -galactosidase
7D). Primers bracketing a Foxo DNA site in the IGFBP1control, luciferase levels were elevated with increasing
promoter were used to probe by PCR the DNA in thelevels of p300 (Figure 5B, lanes 1–5). This finding indi-
immunoprecipitates. p300 (lanes 2 and 7), Foxo1 (lanescates that p300 increases the activity of Foxo3a. Co-
3 and 8), and Foxo3a (lanes 4 and 9) were bound to thetransfection with the SIRT1 vector damped this activa-
DNA site in SIRT1/ and / tissues. SIRT1 was boundtion (Figure 5B, lanes 6–9), which shows that SIRT1
at the Foxo sites in / mice (lane 5) and, as expected,represses the ability of p300 to activate Foxo3a.
was absent in the knockout control (lane 10). The aboveIn a second test of the effect of SIRT1 and p300 on
studies in ES cells and knockout mice validate thatFoxo3a activity, we transfected HEK293T cells with
SIRT1 negatively regulates forkhead-responsive genesFoxo3a (Figure 6, lanes 2–7) without (lane 2) or with
(lanes 3–7) p300. We also cotransfected SIRT1 (lanes in vivo.
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Figure 5. p300 Enhances Transcriptional Activity of Foxo3a while SIRT1 Represses the p300-Mediated Activation of Foxo3a
(A) HEK293T cells were transfected as indicated together with bim-driven luciferase and control -galactosidase vectors. Cells were treated
with wortmannin and LY294002 for the final 6 hr before being lysed in luciferase assay buffer (Promega). Cell lysates were immunoprobed
using an anti-HA antibody (p300), anti-SIRT1, and anti-Foxo3a.
(B) Samples (1–9) from above were assayed for luciferase and -galactosidase activities. The data clearly demonstrate that Foxo3a-dependent
luciferase activity was induced by p300 compared to the -galactosidase control and this induction was dramatically reduced in the presence
of the deacetylase SIRT1.
Discussion reporter constructs, as well as the endogenous target
gene, p27. Third, SIRT1 deacetylates Foxo3a. Fourth,
SIRT1 counteracts p300-mediated activation of Foxo3a.In this report, we investigate a possible connection be-
tween the mammalian SIR2 ortholog, SIRT1, and the Fifth, ES cells in which SIRT1 is knocked out support a
higher level of transactivation of a luciferase reporterforkhead transcription factor, Foxo3a. Several findings
indicate that SIRT1 is a repressor of Foxo3a activity on driven by Foxo DNA binding sites. Sixth, SIRT1 KO mice
display an increase in transcription of Foxo target genes,target genes that are normally activated by this factor.
First, SIRT1 binds to Foxo3a in mammalian cells. Sec- IGFBP1 and PEPCK. Seventh, SIRT1 is present at the
Foxo binding site within the promoter of at least oneond, SIRT1 represses the ability of Foxo3a to activate
Figure 6. SIRT1 Inhibits Foxo3a Activation
of p27
HEK293T cells were transfected as indicated
and lysed 36 hr later. Total cell lysates were
immunoprobed for the presence of SIRT1
(top panel) or for the Foxo3a target p27. The
data show that Foxo3a induces endogenous
p27, coexpression of p300 enhances p27
upregulation, and that this enhancement is
inhibited by the expression of SIRT1. The inhi-
bition by SIRT1 is at least partially dependent
on its deacetylase activity as demonstrated
by the lower efficiency of inhibition of p27
upregulation by the SIRT1dn.
SIRT1 Represses Forkhead
559
Figure 7. Foxo Activity Is Upregulated in
SIRT1 Knockout ES cells and Mice
(A) Wild-type (ESWt) or SIRT1/ (ES
SIRT1/) embryonic stem cells were trans-
fected with 3 g of pGL3-FHRE-luc reporter
construct either without () or with () 1g of
Foxo3a. Luciferase activity was determined
using the dual luciferase kit (Promega), and
the data were normalized to the activity of a
cotransfected CMV renilla plasmid. The error
bars represent the standard deviation of trip-
licate assays.
(B–D) Foxo target genes bind SIRT1 and are
upregulated in SIRT1 knockout mice. (B)
Northern blots of RNA from liver (lanes 1–4)
and kidney (lanes 1–4) of mice of indicated
genotypes were probed for PEPCK. Mice 1
and 2 were littermates, as were mice 3 and
4. The RNA-stained gel is shown as a loading
control. (C) Northern blot of liver RNA from
mice of indicated genotypes was probed for
IGFBP1. Mice A and B were littermates, as
were mice C and D. A negative image of 28S
RNA is shown as a control. (D) Chromatin
immunoprecipitates using the indicated anti-
bodies were probed with primers flanking a
Foxo DNA site in the IGFBP1 promoter. Liver
samples were derived either from SIRT1 wild-
type (SIRT1/. lanes 2–6) or SIRT1/ (lanes
7–11) mice. In lane 1, protein A beads alone
were used as a control. As can be seen, p300,
Foxo1, Foxo3a antibodies precipitate the
DNA site from both the wild-type and
SIRT1/ mouse, while SIRT1 antibodies pre-
cipitate the DNA in the wild-type but not the
SIRT1/ mouse (compare lanes 5 and 10).
Gal-4 antibody (lanes 6 and 11) is used as a
negative control. Lanes 12 and 13 represent
the input DNA from SIRT1/ mice and
SIRT1/ mice.
Foxo target gene in mouse tissue. We also show that proteins. Previous data have suggested that p300 acts
as a transcriptional coactivator for all three mammalianactivation of Foxo3a by UV or oxidative stress increases
its acetylation status. SIRT1 may downregulate acti- Foxo proteins and for C. elegans DAF-16 (Nasrin et al.,
2000). Furthermore the interaction between p300 andvated forkhead by destabilizing the protein, decreasing
its DNA binding activity, or changing protein/protein in- Foxo and the level of Foxo acetylation decreased in
response to growth factor activation (Mahmud et al.,teractions, as suggested for other transcription factors
(Brooks and Gu, 2003). SIRT1 may also mediate repres- 2002). Since we show that SIRT1 also binds to and
deacetylates p300, our data strengthen the claim thatsion at Foxo target genes by deacetylating histones at
those loci. p300 is a coactivator of Foxo proteins.
Our findings link SIRT1 and forkhead, two of the regu-While these studies have focused on the forkhead
factor Foxo3a, our results also indicate that SIRT1 can lators shown to control lifespan in lower organisms. Sur-
prisingly, the regulation of Foxo3a by SIR2 in mammalianrepress Foxo1 and Foxo4, in the latter case mitigating
Foxo-driven apoptosis. SIRT1 may thus generally down- cells is of opposite sign from the apparent regulation in
C. elegans. Why does the mammalian SIRT1 function toregulate genes that are normally activated by forkhead
Cell
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DNA binding sites), pGL2-p27 kip1(luciferase reporter driven by therepress forkhead? In many ways, Foxo seems to parallel
p27 promoter), bim-luc (luciferase reporter driven by the BIM pro-p53 in its functions. Both may play a role in damage
moter), and the plasmid encoding Foxo1A3 are gifts from Dr. R.surveillance and oxidative stress responses. In the case
Medema (NKI), Ha-p300 is a gift from R. Bernards (NKI); Fla- tagged
of Foxo, activation triggers translocation from the cyto- SIRT1 (Luo et al.,2001); pGL2-3XIRS-luc and pGL3-FHRE-luc (gifts
plasm to the nucleus (Rena et al., 2001; Cahill et al., from M. Greenberg, Harvard). Antibodies used: anti-Flag antibody
(Sigma M2, 1:5000 for Western blotting and 2 l for immunoprecipi-2001; Brunet et al., 2002; Tzivion et al., 2001; Henderson
tation), anti-Ha (clone 12CA5, 1:250 for Western blotting and 50l forand Johnson, 2001; Lin et al., 2001; Lee et al., 2001).
immunoprecipitation), anti-acetyl-lysine (Cell Signaling, polyclonalBoth p53 and Foxo appear to interact with the coactiva-
and monoclonal antibodies, 1:1000 for Western blotting and 2 ltor p300 and both are acetylated in the course of their
each for immunoprecipitation), anti-Foxo3a (Upstate 06-951,
activation (Avantaggiati et al., 1997; Nasrin et al., 2000; 1:1000), anti-SIRT1 (Upstate 07-131, 1:5000), anti-p27kip (Transduc-
Mahmud et al., 2002). Both can cause apoptosis, p53 tion laboratories, 1:1000), anti-p300 (Santa Cruz, sc-585), anti-FKHR
(Santa Cruz H-128), anti-GAL4 (Santa Cruz sc-729).in response to damage and Foxo in response to with-
drawal of growth factors and when overexpressed (Bru-
Cell Culture and Reporter Assaysnet et al., 1999; Nakamura et al., 2000; Tang et al., 2002).
HEK293T, HeLa, and U2OS cells were maintained in DMEM 10%The repression of Foxo3a by SIRT1 appears to parallel
fetal calf serum and routinely passaged at 60% confluence.the repression of p53. It is possible that downregulation
HEK293T (100000/well) or HeLa cells (30000) were plated in 12 well
of both of these factors raises the threshold for apopto- plates and the indicated plasmids together with a Foxo3A-depen-
sis and cell senescence (Luo et al., 2001; Langley et al., dent reporter construct (0.1 g in HEK293T cells and 0.5 g in HeLa
cells) were transfected using calcium phosphate (2.5 g total DNA).2002) and mitigates the progressive erosion of organ
To monitor transcriptional activation induced by wild-type Foxo3a,systems with age. It is of interest that Akt/PKB/ mice,
wortmannin (200 nM; Sigma) and LY294002 (10 M; Sigma) werewhich have elevated levels of activated forkhead pro-
added for the final 6 hr to inhibit endogenous PKB activity. Tenteins, are more sensitive to damage-induced apoptosis
millimolar nicotinamide (Sigma), to inhibit SIRT1 activity, was added
and genotoxic stress (Chen et al., 2001). This finding is for 12 hr before lysis. Luciferase activity measurements (Promega
consistent with the suggestion that restraint of forkhead luciferase assay kit) were carried out using an automated Wallach
96 well microplate reader. Data was normalized by assessingactivity may be important in the context of long-term sur-
-galactosidase activity derived from cotransfection with a plasmidvival.
encoding -galactosidase (0.1 g in HEK293T cells and 0.5 g inSIR2 mediates the ability of a low calorie diet to in-
HeLa cells) driven by an SV40 promoter.crease the lifespan in the yeast model system (Lin et
Assessment of Foxo4 activity was determined by transfection of
al., 2000, 2002). If this is also true in mammals, the the indicated constructs together with a reporter construct (pGL2-
regulation of p53 and Foxo proteins by SIRT1 may set 3XIRS-Luc) into U20S cells. Forty-eight hours later, the cells were
lysed and luciferase activity was assessed.the appropriate levels of these factors to achieve longev-
Transfections into mouse embryonic stem cell were performedity under low calorie conditions (Koubova and Guarente,
using GeneJuice (Novagen). Briefly, SIRT1/ or SIRT12/ mouse2003). However, it would seem essential that repression
embryonic stem cells were seeded in 60 mm plates at a density ofof p53 and Foxo by SIRT1 be integrated with other activi-
500000/dish. Cells were cotransfected with 3 g of the indicated
ties of this sirtuin, if cancer is to be avoided and longevity luciferase reporter gene, 2 g of a GFP expressing construct, and
is to be engendered. Calorie-restricted animals display either 1 g of WT Foxo3a or 1 g of empty vector. Forty-eight hours
posttransfection, cells were harvested in lysis buffer and luciferasea reduction in several hormones, including insulin and
activity was assayed according to the Promega protocol. GFP fluo-certain growth factors (Weindruch and Walford, 1988),
rescence was measured on a fluorometer and used to control forchanges that are expected to drive Foxo proteins to the
differences in transfection efficiency.nucleus. This effect may be compensated for by the
downregulation of Foxo by SIRT1 in nuclei of hormone-
Immunoprecipitations and Western Blotting
responsive tissues as a mechanism to avoid excessive HEK293T cells (300000) were plated in six well plates, transfected
apoptosis. Such a reduction in hormonal levels and a using calcium phosphate, and 24 hr later were lysed in 0.5 ml of
lysis buffer (50 mM Tris pH 8.0, 50 mM KCl, 10 mM EDTA, 1%NP40)compensatory desensitization of apoptosis may not re-
containing deacetylase inhibitors (10 mM Nicotinamide and 1 Msult in any net increase in cancer and, in fact, may engen-
TSA), protease inhibitors (Roche EDTA free cocktail), and phospha-der overall stress resistance.
tase inhibitors (20 mM NaF and 1 mM orthovanadate). Lysates wereFinally, the regulation of Foxo by SIRT1 gives this
immunoprecipitated (12 hr), washed three times with 50 mM Tris
sirtuin a window into many forkhead-mediated meta- (pH 7.5) (5 mM EDTA, 150 mM NaCl 0.1% tween 20), and were
bolic changes in mammals (Tran et al., 2003; Kamei et probed by Western blotting.
al., 2004; Nadal et al., 2002; Nakae et al., 2002, 2003).
SIRT1 may therefore play an important role in altering Apoptosis Analysis
H1229 cells were transfected as indicated together with GFP tometabolism in response to diet, for example impinging
mark cells that were transfected. After a further incubation of 48 hr,on gluconeogenesis, insulin secretion/action, lipid us-
the cells were harvested, fixed, stained with propidium idodide, andage, and ketogenesis, during calorie restriction. Tuning
analyzed by flow cytometry. The sub-G1 peak was used to assess
the metabolism and stress resistance to the diet may the % of apoptotic cells.
help engender the long life observed on a low calorie
regimen. Stress Treatments
Confluent HeLa cells were either maintained as controls, UVC irradi-
ated (200 Joules/cm2), or treated with H2O2 (500 m 2 hr laterExperimental Procedures
Nicotinamide (10 mM) or TSA (1 M) was added for 1 hr and lysed
using IP lysis buffer (50 mM Tris [pH 8.0], 10 mM EDTA, 50 mMPlasmids and Antibodies
pECHA-Foxo3a and Foxo3aA3 (mutated in the three PKB phosphor- KCl, 0.2%NP40, 10% glycerol) containing protease inhibitors (Roche
complete protease tablets), 10 mM nicotinamide, 1 M TSA, 1 mMylation sites T32, S253, and S315 all converted to alanines), DBE-
luciferase (a luciferase reporter construct driven by synthetic Foxo orthovanadate, and 20 mM NaF. Endogenous Foxo3a was immuno-
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precipitated and Western blotted using anti-acetyl-lysine antibodies Akt promotes cell survival by phosphorylating and inhibiting a Fork-
head transcription factor. Cell 96, 857–868.(Upstate, polyclonal and monoclonal, 1:1000 diluted in PBS tween
0.2%, 5% BSA). Brunet, A., Kanai, F., Stehn, J., Xu, J., Sarbassova, D., Frangioni,
J.V., Dalal, S.N., DeCaprio, J.A., Greenberg, M.E., and Yaffe, M.B.
Northern Blot Analysis (2002). 14–3-3 transits to the nucleus and participates in dynamic
Total RNA was extracted from mice of the indicated SIRT1 geno- nucleocytoplasmic transport. J. Cell Biol. 156, 817–828.
types (129/Sv CD1 mixed background) using guanidium thiocyanate, Cahill, C.M., Tzivion, G., Nasrin, N., Ogg, S., Dore, J., Ruvkun, G.,
separated on 1.2% agarose, transferred to nitrocellulose, and hy- and Alexander-Bridges, M. (2001). Phosphatidylinositol 3-kinase
bridized according to standard procedures with 32P-labeled probes signaling inhibits DAF-16 DNA binding and function via 14–3-3-
specific for murine phosphoenolpyruvate carboxylase (PEPCK) or dependent and 14–3-3-independent pathways. J. Biol. Chem.
insulin-like growth factor binding protein 1 (IGFBP1). 276, 13402–13410.
Chen, W.S., Xu, P.Z., Gottlob, K., Chen, M.L., Sokol, K., Shiyanova,Chromatin Immunoprecipitation
T., Roninson, I., Weng, W., Suzuki, R., Tobe, K., et al. (2001). GrowthAssay was performed on 4-month-old females (129/Sv CD1 mixed
retardation and increased apoptosis in mice with homozygous dis-background) as previously described (Wells et al., 2000; Weinmann
ruption of the Akt1 gene. Genes Dev. 15, 2203–2208.et al. 2001) using a protocol for mouse tissues (http://mcardle.
Cheng, H.L., Mostoslavsky, R., Saito, S., Manis, J.P., Gu, Y., Patel,oncology.wisc.edu/farnham/protocols/tissues.html) with the follow-
P., Bronson, R., Appella, E., Alt, F.W., and Chua, K.F. (2003). Devel-ing modifications: (1) formaldehyde crosslinking was for 1 hr; (2)
opmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-protein A Sepharose was used; (3) preclear was for 1 hr; (4) centrifu-
deficient mice. Proc. Natl. Acad. Sci. USA 100, 10794–10799.gation step (14000 rpm for 20 min) was included after incubation
with primary antibody; (5) immunoprecipitates were washed two Daitoku, H., Yamagata, K., Matsuzaki, H., Hatta, M., and Fukamizu,
times with IP dilution buffer, two times with 0.1% SDS, 1% Triton A. (2003). Regulation of PGC-1 promoter activity by protein kinase
X100, 2 mM EDTA, 20 mM TrisHCl, pH 8, 500 mM NaCl, two times B and the forkhead transcription factor FKHR. Diabetes 52, 642–649.
with IP wash buffer, two times with TE 1X; (6) DNA complexes were Dijkers, P.F., Medema, R.H., Pals, C., Banerji, L., Thomas, N.S., Lam,
eluted using 50 mM TrisHCl, pH 8, 1% SDS 10 mM EDTA; (7) after E.W., Burgering, B.M., Raaijmakers, J.A., Lammers, J.W., Koender-
reversion of formaldehyde crosslink, DNA was recovered by diluting man, L., and Coffer, P.J. (2000). Forkhead transcription factor FKHR-
the samples with milli Q water to 0.5% SDS, 5 mM EDTA, 25 mM L1 modulates cytokine-dependent transcriptional regulation of
TrisHCl, 100 mM NaCl, treating with proteinase K (1 mg/ml for 2 hr p27(KIP1). Mol. Cell. Biol. 20, 9138–9148.
at 37C), extracting with phenol, chloroform followed by ethanol
Frye, R.A. (1999). Characterization of five human cDNAs with homol-precipitation in the presence of 5 g glycogen and Na acetate (300
ogy to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolizemM). DNA was washed with 70% Ethanol, dried, resuspended in
NAD and may have protein ADP-ribosyltransferase activity. Bio-TE, and analyzed by PCR. Immunoprecipitations were performed
chem. Biophys. Res. Commun. 260, 273–279.with 1 g of the indicated antibodies. IGFBP1 primers (available
Fulco, M., Schiltz, R.L., Iezzi, S., King, M.T., Zhao, P., Kashiwaya,upon request) span the Foxo binding site (Tomizawa et al., 2000;
Y., Hoffman, E., Veech, R.L., and Sartorelli, V. (2003). Sir2 regulatesHall et al., 2000).
skeletal muscle differentiation as a potential sensor of the redox
state. Mol. Cell 12, 51–62.Acknowledgments
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